Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2654 |
|
| Actual shortage: | 249 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2396 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
26 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ZOPICLONE | 5MG | TABLET | Actual shortage | 2023-02-02 | 2024-02-01 | 183386 |
| TEVA-OLANZAPINE | 5MG | TABLET | Resolved | 2023-02-02 | 2023-04-28 | 183389 |
| ACT FLUCONAZOLE | 100MG | TABLET | Resolved | 2023-02-02 | 2023-10-04 | 183392 |
| ACT ENALAPRIL | 16MG | TABLET | Resolved | 2023-02-02 | 2023-07-12 | 183395 |
| TEVA-LISINOPRIL/HCTZ (TYPE Z) | 25MG 20MG | TABLET | Resolved | 2023-02-02 | 2023-02-16 | 183398 |
| TEVA-LETROZOLE | 2.5MG | TABLET | Resolved | 2023-02-02 | 2023-10-06 | 183404 |
| TEVA-TRAMADOL/ACETAMINOPHEN | 37.5MG 325MG | TABLET | Resolved | 2023-02-02 | 2023-06-09 | 183407 |
| TEVA-OLANZAPINE | 20MG | TABLET | Resolved | 2023-02-02 | 2023-04-28 | 183410 |
| TEVA-CANDESARTAN | 16MG | TABLET | Resolved | 2023-02-02 | 2023-06-09 | 183413 |
| TEVA-EXEMESTANE | 25MG | TABLET | Resolved | 2023-02-02 | 2023-04-28 | 183416 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Resolved | 2023-02-02 | 2023-02-09 | 183425 |
| TEVA-TELMISARTAN | 40MG | TABLET | Resolved | 2023-02-09 | 2023-04-28 | 184171 |
| TEVA-FUROSEMIDE | 40MG | TABLET | Resolved | 2023-02-09 | 2023-06-09 | 184174 |
| TEVA-PROPRANOLOL | 10MG | TABLET | Resolved | 2023-02-09 | 2023-07-12 | 184177 |
| TEVA-PROPRANOLOL | 40MG | TABLET | Resolved | 2023-02-09 | 2023-07-12 | 184180 |
| TEVA-DOMPERIDONE | 10MG | TABLET | Resolved | 2023-02-09 | 2023-06-09 | 184183 |
| ACT TERBINAFINE | 250MG | TABLET | Resolved | 2023-02-09 | 2023-07-05 | 184195 |
| TEVA-BETAHISTINE | 16MG | TABLET | Resolved | 2023-02-09 | 2023-06-09 | 184198 |
| TEVA-BETAHISTINE | 24MG | TABLET | Resolved | 2023-02-09 | 2023-07-06 | 184201 |
| ACT AMLODIPINE | 5MG | TABLET | Resolved | 2023-02-09 | 2023-04-28 | 184204 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81337 | ||
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81344 | ||
| HYDROCORTISONE SODIUM SUCCINATE INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81347 | ||
| TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106136 | ||
| TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106139 | ||
| RATIO-SALBUTAMOL | Discontinued | 2020-02-13 | 2020-02-13 | 106151 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106155 | ||
| EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106170 | ||
| LINEZOLID INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106173 | ||
| EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106176 |